Raptor Pharmaceutica (RPTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 08-2011 | 08-2010 | 08-2009 | 12-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,195 | -18,928 | -9,224 | -22,785 | -23,369 |
| Depreciation Amortization | 231 | 225 | 223 | 706 | 892 |
| Accounts payable and accrued liabilities | 210 | 24 | 48 | -1,597 | 1,205 |
| Other Working Capital | 1,219 | -58 | 72 | -900 | 958 |
| Other Operating Activity | 18,316 | 6,166 | 355 | 3,672 | 620 |
| Operating Cash Flow | $-17,219 | $-12,571 | $-8,526 | $-20,904 | $-19,694 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -50 | -21 | -23 | 345 | -351 |
| Net Acquisitions | N/A | 581 | N/A | N/A | N/A |
| Purchase Of Investment | -114 | N/A | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | 42 | N/A |
| Investing Cash Flow | $-164 | $561 | $-23 | $387 | $-351 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | N/A | N/A | 3,600 | N/A |
| Debt Repayment | -5 | -4 | -3 | -4,693 | -3,201 |
| Common Stock Issued | 15,749 | 27,994 | 5,001 | 22 | 50 |
| Other Financing Activity | -152 | -2,720 | -294 | -48 | 0 |
| Financing Cash Flow | $15,592 | $25,270 | $4,703 | $-1,119 | $-3,151 |
| Exchange Rate Effect | 10 | -8 | N/A | N/A | 313 |
| Beginning Cash Position | 16,953 | 3,702 | 7,547 | 32,500 | 55,383 |
| End Cash Position | 15,172 | 16,954 | 3,702 | 10,864 | 32,500 |
| Net Cash Flow | $-1,781 | $13,252 | $-3,845 | $-21,636 | $-22,883 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,219 | -12,571 | -8,526 | -20,904 | -19,694 |
| Capital Expenditure | -50 | -21 | -23 | -19 | -351 |
| Free Cash Flow | -17,269 | -12,592 | -8,548 | -20,923 | -20,045 |